23andMe is Sold to Regeneron:  What happens now? 

Genetic Data, Genomic & Genetics Issues, uncategorized, United States / /

Joyce A. Shelton, Ph.D.

Professor of Biology Emerita

Trinity International University

The direct to consumer genetic testing company 23andMe, has been in bankruptcy. On May19th of this year they announced that they have sold the company and all of its assets to Regeneron Pharmaceuticals for 256 million dollars. This sale means that Regeneron acquires 23andMe’s gigantic genetic databank garnered from approximately 15 million customers. Given the uniquely personal identifying information about themselves and family members that consumers share when they submit their genetic samples to companies like 23andMe, issues surrounding data security and privacy have long been a cause for ...read more

23andMe is Sold to Regeneron:  What happens now?  Read More »

Choppy Waters in the Gene Pool: 23andMe is Going Under

Blog, Genetic Data / /

by Joyce A. Shelton, Ph.D.

Professor of Biology Emerita Trinity International University 

23andMe, the personal genetic testing company is drowning. Around this time a year ago, we wrote about the massive database hack in which the genetic profiles of 6.9 million 23andMe customers were stolen and offered for sale on the internet, a severe attack on their privacy. Since then, the once thriving company has been on a steadily downward trajectory. Pretty quickly they were hit with a $30 million class action lawsuit resulting in $10,000 individual payouts to victims. Two months ago their stock was in serious trouble and their entire ...read more

Choppy Waters in the Gene Pool: 23andMe is Going Under Read More »